Published on in Vol 8, No 9 (2019): September
Journals
- Hecker-Nolting S, Langer T, Blattmann C, Kager L, Bielack S. Current Insights into the Management of Late Chemotherapy Toxicities in Pediatric Osteosarcoma Patients. Cancer Management and Research 2021;Volume 13:8989 View
- Bielack S, Kager L, Kühne T, Langer T, Reichardt P, Blattmann C, Kevric M, Mettmann V, Sorg B, Hecker-Nolting S. Establishment, Maintenance, and Performance of the Cooperative Osteosarcoma Study Group (COSS). Cancers 2023;15(5):1520 View
- Kondratowski S, Cohen D, Deyell R, Sandhu A, Bush J, Li Z. Immunohistochemical study of histone protein 3 modification in pediatric osteosarcoma identifies reduced H3K27me3 as a marker of poor treatment response. PLOS ONE 2024;19(11):e0309471 View